That's a straw-man argument—I didn't say anything about continuous updating.
Many small biotech companies do give periodic updates on enrollment by providing actual numbers rather than boilerplate language (as PPHM does). EXAS and AMRN are two cases in point.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.